LCK and cancer: In agreement, we demonstrated that treatment with αCD61 neutralizing antibody led to a significant downregulation of Lck expression on WT CD61+ T cell lines of seven different patients with cancer (Fig. 3f), suggesting that CD61 is a modulator of Lck-dependent Zap70 phosphorylation.